| 000 | 01373nam a2200385 a 4500 | ||
|---|---|---|---|
| 005 | 20250918142124.0 | ||
| 008 | 110602s2011 xxka 001 0 eng | ||
| 020 |
_a9781405181044 _cRM363.23 |
||
| 039 | 9 |
_a201202201258 _bzainol _c201106131646 _dzaleha _c201106071303 _dzaleha _y06-02-2011 _zbalqis |
|
| 040 | _dUKM | ||
| 060 |
_aWG120 _b.M587 2011 9HUKM |
||
| 090 | _aWG120.M587 2011 9HUKM | ||
| 090 |
_aWG120 _b.M587 2011 9 |
||
| 245 | 0 | 0 |
_aMetabolic risk for cardiovascular disease / _cedited by Robert H. Eckel |
| 260 |
_aChichester : _bWiley-Blackwell, _c2011 |
||
| 300 |
_axi, 244 p. : _bill. ; _c24 cm. |
||
| 490 | 1 | _aAHA clinical series | |
| 650 | 2 |
_aCardiovascular Diseases _xetiology |
|
| 650 | 2 |
_aMetabolic Syndrome X _xcomplications |
|
| 650 | 2 |
_aDiabetes Mellitus, Type 2 _xcomplications |
|
| 650 | 2 |
_aCardiovascular Diseases _xepidemiology |
|
| 650 | 2 |
_aCardiovascular Diseases _xprevention & control |
|
| 650 | 2 | _aRisk factors | |
| 700 | 1 | _aEckel, Robert H. | |
| 710 | 2 | _aAmerican Heart Association | |
| 830 | 0 | _aAHA clinical series | |
| 907 |
_a.b15051961 _b2021-05-28 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWG120.M587 2011 9HUKM |
||
| 914 | _avtls003467664 | ||
| 990 | _aNHR/Mazura | ||
| 991 | _aJabatan Perubatan, PPUKM | ||
| 991 | _aJabatan Bioperubatan, KKL | ||
| 998 |
_ad _ah _b2011-02-06 _cm _da _feng _gxxk _y0 _z.b15051961 |
||
| 999 |
_c489871 _d489871 |
||